You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute lymphocytic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphocytic Leukemia
  • CD19 CAR-T cells
  • Suzhou, China
    The First Affiliated Hospital of Soochow University
Jan 11, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

BESPONSA Injection 1 mg Special Investigation

Active, not recruiting
  • Acute Lymphocytic Leukemia
    • Tokyo, Japan
      Pfizer
    Jun 20, 2023

    Acute Lymphocytic Leukemia Trial in Beijing, Tianjin (LCAR-AIO Cells)

    Recruiting
    • Acute Lymphocytic Leukemia
    • LCAR-AIO Cells
    • Beijing, Beijing, China
    • +1 more
    May 31, 2022

    Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

    Not yet recruiting
    • Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 23, 2022

    Drug Induced Neuropathy in Children With ALL

    Recruiting
    • Acute Lymphocytic Leukemia
      • Trieste, Friuli Venezia Giulia, Italy
        IRCCS materno infantile Burlo Garofolo
      Mar 31, 2023

      T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

      Recruiting
      • T-Cell Acute Lymphocytic Leukemia
      • CD7 CAR-T
      • Langfang, Hebei, China
        Hebei Yanda Hospital
      Jun 26, 2023

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

      Not yet recruiting
      • Acute Myelogenous Leukemia
      • +17 more
      • Peripheral Blood Stem Cell Transplant
      • +7 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Mar 27, 2023

      ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

      Not yet recruiting
      • ALL, Childhood B-Cell
      • +2 more
      • Tafasitamab
      • (no location specified)
      Nov 25, 2022

      Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 5, 2023

      Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))

      Not yet recruiting
      • Lymphoma Leukemia
      • allogeneic CAR19 regulatory T cells (CAR19-tTreg)
      • +2 more
      • Minneapolis, Minnesota
        Masonic Cancer Center - University of Minnesota
      Dec 6, 2022

      Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Depocyt, Dexamethasone)

      Completed
      • Adult Acute Lymphocytic Leukemia
      • Frankfurt, Germany
        University Hospital, Medical Dept. II
      Aug 16, 2022

      Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

      Completed
      • Multiple Myeloma
      • +11 more
      • Pre-biotic foods/drinks
      • Charlottesville, Virginia
        University of Virginia
      Jan 2, 2023

      B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

      Active, not recruiting
      • B-Lymphoid Malignancies
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Aug 1, 2022

      Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Beijing (CAR-NK-CD19 Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • +2 more
      • CAR-NK-CD19 Cells
      • Beijing, Beijing, China
        Beijing Boren Hospital
      Jun 5, 2022

      Venetoclax Tablets Crushed and Dissolved Into a Solution

      Not yet recruiting
      • Hematologic Malignancy
      • +18 more
      • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Nov 8, 2023

      Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

      Completed
      • Adult Acute Lymphocytic Leukemia
      • Frankfurt, Germany
        University of Frankfurt, Medical Dept. II
      Aug 17, 2022

      Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary

      Recruiting
      • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +8 more
      • Scottsdale, Arizona
      • +1 more
      May 16, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Acute Lymphocytic Leukemia, Acute Myeloid Leukemia Trial in Fairway (Daunorubicin)

      Completed
      • Acute Lymphocytic Leukemia
      • Acute Myeloid Leukemia
      • Fairway, Kansas
        University of Kansas Cancer Center - Clinical Research Center
      Jan 12, 2022

      Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

      Not yet recruiting
      • Acute Leukemia
      • +4 more
      • Haploidentical hematopoietic cell transplantation (haploHCT)
      • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
      • (no location specified)
      Jul 13, 2022

      Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

      Recruiting
      • Non Hodgkin Lymphoma
      • +2 more
      • Fully human anti CD19 CAR-T Cell Dose
      • +2 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Oct 4, 2022

      Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

      Active, not recruiting
      • Acute Lymphocytic Leukemia
      • Lymphoma
      • Biological/Genetically Modified T cells
      • Cyclophosphamide-based chemotherapy
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2023

      Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

      Recruiting
      • Relapsed/Refractory Leukemias
      • +4 more
      • Kansas City, Missouri
      • +1 more
      Jul 18, 2022

      Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

      Completed
      • Chronic Myelogenous Leukemia
      • +9 more
      • Atlanta, Georgia
        Northside Hospital
      Apr 4, 2022